vaccinia prostate-specific antigen vaccine
Vaccineexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 1999 (NCT00003871)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Prostate specific antigenImmunity, active
KLK3 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vaccinia prostate-specific antigen vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00045227 | Phase 2 | Aug 1, 2002 | National Cancer Institute (NCI) |
| NCT00020254 | Phase 2 | Jun 1, 2000 | National Cancer Institute (NCI) |
| NCT00005039 | Phase 2 | Jan 1, 2000 | Harvard University, National Cancer Institute (NCI) |
| NCT00003871 | Phase 2 | Aug 1, 1999 | Eastern Cooperative Oncology Group, National Cancer Institute (NCI), Yeshiva University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 4 | 3 | 1 | 1999 |
| Eastern Cooperative Oncology Group | Academic/Hospital | 1 | 1 | 1 | 1999 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2000 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 1999 |
4 organizations
Page 1 / 1